Funded Tech Companies
Inipharm
Researching who provided funding to Inipharm? Jubilant Biosys, Frazier Healthcare Partners and 5AM Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Inipharm
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
500 108th Ave. NE 1100
Bellevue, WA 98004
USA
Bellevue, WA 98004
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Highly Validated Approaches to Highly Unmet Need. Developing Treatments for Severe Liver Disease. At Inipharm, we're building on novel insights and applying our chemistry expertise to develop therapies for patients with liver disease. Inipharm's lead program is focused on small-molecules to target the activity of HSD17B13, a highly validated, genetically defined target for liver and related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/12/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Farmer
Chief Scientific Officer
Heather Hsu
Vice President
Vince Florio
Vice President
Joshua Odingo
Company Investors
- Jubilant Biosys
- Frazier Healthcare Partners (Daniel Estes)
- 5AM Ventures (Brian Daniels)
- Wu Capital (Hannah Chang)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs